Digital Health Implementation Strategies to Improve Lung Cancer Screening Among Safety-Net Clinics
LUNG-IS
2 other identifiers
interventional
800
1 country
1
Brief Summary
The long-term goal of this program of research is to increase the reach of Lung Cancer Screening (LCS) among low-resource healthcare settings and populations. The proposed project, LUNG-IS, is a mixed-methods, pre-post quasi-experimental design conducted in three Utah safety-net healthcare system clinics. LUNG-IS employs a comprehensive conceptual model with theories, models, and frameworks of implementation and behavioral science, uses rigorous mixed-methods to evaluate factors that influence implementation of LCS, and uses patient navigation to facilitate clinic-community linkages. LUNG-IS leverages existing pathways to care and Centralized Hub infrastructure that enables eligibility assessment, LCS Shared Decision Making (SDM) with clinical decision support, screening referral, and screening logistics assistance to help overcome barriers to LCS completion. The Centralized Hub model uses ubiquitous technologies (i.e., text messaging/telehealth) to enable patients to be assessed for LCS eligibility, engage in SDM if eligible, and be referred for LCS. For patients who decide to complete LCS, they will be provided patient navigation via Community Health Workers designed to address logistical barriers, hesitancy, and financial constraints around completing LCS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable lung-cancer
Started Jan 2026
Shorter than P25 for not_applicable lung-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
July 2, 2026
CompletedFirst Posted
Study publicly available on registry
July 21, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 1, 2027
July 21, 2026
July 1, 2026
1 year
July 2, 2026
July 15, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Impact of Implementation Strategies on Lung Cancer Screening (LCS) eligibility screening
Evaluate the impact of implementation strategies on Lung Cancer Screening (LCS) eligibility screening. This outcome measure will report the proportion of participants who complete LCS eligibility screening.
up to 15 weeks after study enrollment
Secondary Outcomes (2)
Impact of Implementation Strategies on LCS Shared Decision Making (SDM) completion
up to 7 weeks after completion of LCS eligibility screen
Impact of Implementation Strategies on LCS Completion
up to 6 months after placement of LCS referral
Study Arms (6)
Stage 1: TM+
OTHERBasic text messages sent directly to the patient's cell phone.
Stage 1: TM+, CA
OTHERBasic text messages sent directly to the patient's cell phone. Also includes the option for chat bot to answer frequently asked LCS questions.
Stage 1: TM+, Video
OTHERBasic text messages sent directly to the patient's cell phone. Also includes the option for an educational video about LCS.
Stage 1: TM+, CA, Video
OTHERBasic text messages sent directly to the patient's cell phone. Also includes the option for chat bot to answer frequently asked LCS questions and option for educational video about LCS. Patients who complete SDM and are referred to LCS will also be assigned to one of the following conditions. Descriptions of these conditions are as follows:
Stage 2: TM+, RPN
OTHERPatients who complete SDM and are referred to LCS may be assigned to this condition Patients will receive basic text messages and reactive patient navigation to help get to the LCS appointment.
Stage 2:TM+, PPN
OTHERPatients who complete SDM and are referred to LCS may be assigned to this condition Patients will receive basic text messages and proactive patient navigation to help get to the LCS appointment. Patients who need transportation financial assistance will receive transportation vouchers to help get them to and from their LCS appointment.
Interventions
Basic text messages sent directly to the patient's cell phone.
Chat bot to answer frequently asked LCS questions.
Proactive patient navigation to help get to the LCS appointment.
Reactive patient navigation to help get to the LCS appointment.
Eligibility Criteria
You may qualify if:
- Current or former, male and female, smokers.
- Age 50-80.
- Primary language English or Spanish.
- Have a phone that can send/receive text messages.
You may not qualify if:
- Patients who have never smoked.
- Patients who are under the age of 50 or above the age of 80.
- Primary language other than English or Spanish.
- Do not have access to a phone that can send/receive text messages.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- Centers for Disease Control and Preventioncollaborator
Study Sites (1)
Huntsman Cancer Institute/ University of Utah
Salt Lake City, Utah, 84112, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chelsey Schlechter, MPH, PhD
Huntsman Cancer Institute/ University of Utah
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 2, 2026
First Posted
July 21, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
January 1, 2027
Study Completion (Estimated)
January 1, 2027
Last Updated
July 21, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share